This term indicates that something, such as an application, product, or plan, has received preliminary assent but requires the fulfillment of specific conditions or stipulations before full and final endorsement is granted. For example, a loan might be granted, pending verification of income and collateral, or a drug may be allowed on the market subject to ongoing monitoring for side effects.
The significance of this interim status lies in its ability to facilitate progress while mitigating potential risks. It enables stakeholders to move forward with reasonable assurance, knowing that continued advancement hinges on meeting pre-defined criteria. Historically, its use has allowed for expedited processes in sectors where delays can have significant consequences, such as pharmaceutical development during public health emergencies, while maintaining a level of regulatory oversight.